hsa-miR-486-5p inhibits tumor growth and improves chemotherapy sensitivity by targeting PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) and TWF1 (twinfilin actin binding protein 1), respectively (Jin et al., 2019; Tian et al., 2019). The gene discussed is PIK3R1; the disease is neoplasm.